Rhythm Pharmaceuticals, Inc. (RYTM) stock
RYTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30268% above fair value
$116.61+9.13 (+8.49%)
Close on Nov 17, 2026Market cap $8.03BP/E –Yield –
Rhythm Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Rhythm Pharmaceuticals's price to book ratio was 74.9× on Nov 11, 2026, against 48.9× a year earlier. Over the last 5 years it ranged from 0.7× to 339.9×, with a median of 15.2×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 74.9× | +27.0 |
| 2025 | Dec 31, 2025 | 48.0× | −258.7 |
| 2024 | Dec 31, 2024 | 306.7× | +292.9 |
| 2023 | Dec 29, 2023 | 13.8× | +8.0 |
| 2022 | Dec 30, 2022 | 5.8× | +4.2 |
| 2021 | Dec 31, 2021 | 1.6× | −5.1 |
| 2020 | Dec 31, 2020 | 6.7× | +1.3 |
| 2019 | Dec 31, 2019 | 5.3× | +1.9 |
| 2018 | Dec 31, 2018 | 3.4× | – |
See a number that looks wrong?